Biotin, Cyanokobalamin, Folsyre, Natriumaskorbat, Natriumpantotenat, Nikotinamid, Pyridoksinhydroklorid, Riboflavinnatriumfosfat, Tiaminnitrat shortage — US supply status & alternatives

Biotin, Cyanokobalamin, Folsyre, Natriumaskorbat, Natriumpantotenat, Nikotinamid, Pyridoksinhydroklorid, Riboflavinnatriumfosfat, Tiaminnitrat

—

In supply · Australia

Soluvit pulver til infusjonsvæske, oppløsning

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Biotin, Cyanokobalamin, Folsyre, Natriumaskorbat, Natriumpantotenat, Nikotinamid, Pyridoksinhydroklorid, Riboflavinnatriumfosfat, Tiaminnitrat
Brand names	Soluvit pulver til infusjonsvæske, oppløsning
Therapeutic category	Auto-created by NoMA (Norwegian Medicines Agency / DMP) scraper
Controlled substance	No
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 1 resolved event

◷

~1 month

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 1mo ago

High

🇳🇴

Norway

NOMA · 23h ago

Resolved

Recalls official enforcement reports

🇺🇸

Biotin Solution For Injection

ASP CARES · Nov 2021

Class IIdetails ↗

🇺🇸

Biotin Suspension

Partell Specialty Pharmacy · Mar 2018

Class IIdetails ↗

🇺🇸

Biotin Usp (Vitamin H) For Prescription Compounding

American Pharmaceutical Ingredients LLC · Feb 2018

Class IIdetails ↗

Verified timeline regulator events

🇳🇴 19 Jan 2026

Shortage resolved

🇺🇸 30 July 2025

high reported

🇺🇸 7 Mar 2022

high reported

Sources official regulators

🇳🇴

NOMA

verified 23h ago

verify ↗

🇺🇸

FDA MedWatch

verified 1mo ago

verify ↗

Mederti Drug Report

Generated 6 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.